Current monitoring and treatment of progressive fibrosing interstitial lung disease: a survey of physicians in Japan, the United States, and the European Union.

Conclusions Awareness and management of progressive fibrosing ILD varied between specialties and regions, highlighting an unmet need for standardized diagnosis, treatment guidelines, and specialist education in this area. PMID: 33287583 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33287583?dopt=Abstract

Source: Current Medical Research and Opinion - December 10, 2020 Category: Research Tags: Curr Med Res Opin Source Type: research